Glass House Brands (GLASF) Investor Day 2024 summary

Strategic vision and market positioning

• Focused on low-cost, high-quality cannabis cultivation in California, aiming to be the lowest-cost provider and leveraging vertical integration for data and margin advantages.

• Expansion plans are built for a post-prohibition world, with readiness to scale nationally as regulations evolve, including optionality between cannabis and hemp production via Greenhouse II.

• Emphasis on brand building, with Allswell, Glass House Farms, and PLUS positioned for different consumer segments; Allswell is now a top-three flower brand in California.

• Retail strategy leverages 10 stores for direct consumer feedback, data, and margin optimization, outperforming the stagnant California market with 6% YoY growth in Q2 2024.

• Product innovation and loyalty programs are driving customer engagement and sales, with launches like Allswell vapes and solventless PLUS gummies.

Financial guidance and capital allocation

• Raised full build-out production estimates from 1.5 million to 1.6 million pounds, adding $25 million in potential revenue at $250/lb ASP.

• Targeting $100 per pound production cost, with a clear roadmap and ongoing cost reductions through automation and process improvements.

• Scenario analysis shows EBITDA margins from low 20% in tough markets to 44% with interstate sales at a 50% premium, with revenue potential near $700 million.

• Phase 3 expansion (GH2) will require $25M–$30M in capex, targeting first revenue by end of 2025 and projected to deliver a pre-tax payback in ~10 months, with 275K pounds produced in year one.

• Funding for expansion will focus on equity issuance, with no major debt maturities in the next two years and the ability to pay obligations from operating cash flow.

Expansion and regulatory strategy

• Greenhouse II conversion budgeted at $25–$30 million, with a 10-month timeline once orders are placed; decision on hemp vs. cannabis expected in Q2.

• Applied for a hemp license to enable out-of-state sales under the Farm Bill, with regulatory monitoring and beta testing underway.

• Interstate commerce presents a major upside, as wholesale prices in Midwestern and Eastern states are significantly higher than in California, and Glass House is prepared to capitalize if regulations allow.

• Risks include regulatory changes at state and federal levels, potential backlash from MSOs, and the need to keep operations compliant and separated.

• If federal rules change, facilities can revert to California cannabis production without disruption.